Evidence map›Paper›PMID 25220409›Full record

ArticleMayo Clinic proceedings2014

Prevalence of multimorbidity in a geographically defined American population: patterns by age, sex, and race/ethnicity.

Walter A Rocca, Cynthia M Boyd, Brandon R Grossardt, William V Bobo, Lila J Finney Rutten, Véronique L Roger, Jon O Ebbert, Terry M Therneau, Barbara P Yawn, Jennifer L St Sauver

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Mayo Clinic proceedings, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed, 4 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 4 syntheses or guidelines pooled it, 250 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Multimorbidity in Atrial Fibrillation: Impact on Outcomes.Journal of the American Heart Association · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Comparison of plasma p-tau217/Aβ42, p-tau217, and Aβ42/Aβ40 biomarkers by race to detect Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Walter A RoccaDivision of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN; Department of Neurology, College of Medicine, Mayo Clinic, Rochester, MN. Electronic address: rocca@mayo.edu.
Cynthia M BoydDivision of Geriatric Medicine and Gerontology, School of Medicine, Johns Hopkins University, Baltimore, MD.
Brandon R GrossardtDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN.
William V BoboDepartment of Psychiatry, College of Medicine, Mayo Clinic, Rochester, MN.
Lila J Finney RuttenDivision of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, College of Medicine, Mayo Clinic, Rochester, MN.
Véronique L RogerDivision of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN; Division of Cardiovascular Diseases, Department of Internal Medicine, College of Medicine, Mayo Clinic, Rochester, MN; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, College of Medicine, Mayo Clinic, Rochester, MN.
Jon O EbbertRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, College of Medicine, Mayo Clinic, Rochester, MN.
Terry M TherneauDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN.
Barbara P YawnDivision of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN; Department of Research, Olmsted Medical Center, Rochester, MN.
Jennifer L St SauverDivision of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, College of Medicine, Mayo Clinic, Rochester, MN.
Mayo Clinic · USMayo Clinic in Arizona · USMayo Clinic in Florida · USJohns Hopkins Medicine · US

Funding

Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
Treatment Burden in Older Adults with Diabetes and MultimorbidityK23AG032910 · NIA · JOHNS HOPKINS UNIVERSITY · PI BOYD, CYNTHIA MELINDA · 2009 to 2013
$533k
NIA NIH HHS K23 AG032910NIA NIH HHS R01 AG034676NIA NIH HHS R01-AG034676
6 · The paper itself

Abstract

objectiveTo describe the prevalence of multimorbidity involving 20 selected chronic conditions in a geographically defined US population, emphasizing age, sex, and racial/ethnic differences. PATIENTS AND

methodsUsing the Rochester Epidemiology Project records linkage system, we identified all residents of Olmsted County, Minnesota, on April 1, 2010, and electronically extracted the International Classification of Diseases, Ninth Revision codes associated with all health care visits made between April 1, 2005, and March 31, 2010 (5-year capture frame). Using these codes, we defined the 20 common chronic conditions recommended by the US Department of Health and Human Services. We counted only persons who received at least 2 codes for a given condition separated by more than 30 days, and we calculated the age-, sex-, and race/ethnicity-specific prevalence of multimorbidity.

resultsOf the 138,858 study participants, 52.4% were women (n=72,732) and 38.9% had 1 or more conditions (n=54,012), 22.6% had 2 or more conditions (n=31,444), and 4.9% had 5 or more conditions (n=6853). The prevalence of multimorbidity (≥2 conditions) increased steeply with older age and reached 77.3% at 65 years and older. However, the absolute number of people affected by multimorbidity was higher in those younger than 65 years. Although the prevalence of multimorbidity was similar in men and women overall, the most common dyads and triads of conditions varied by sex. Compared with white persons, the prevalence of multimorbidity was slightly higher in black persons and slightly lower in Asian persons.

conclusionMultimorbidity is common in the general population; it increases steeply with older age, has different patterns in men and women, and varies by race/ethnicity.

Indexed as

AdolescentAdultAgedAge DistributionChildChild, PreschoolComorbidityDiseaseEthnicityFemaleHumansInfantInfant, NewbornMaleMiddle AgedMinnesota

Identifiers

PMID25220409
PMCPMC4186914
OpenAlexW29873225

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.